Tailored release drug delivery system for rifampicin and isoniazid for enhanced bioavailability of rifampicin

Pharmaceutical Development and Technology
Amelia M Avachat, Satish B Bhise

Abstract

The front line antitubercular drugs rifampicin (RMP) and isoniazid (INH), when co-administered, face the problem of reduced bioavailability of RMP. Stabilization of RMP in the presence of INH under acidic environment may improve the bioavailability of RMP. In vitro degradation studies showed around 15-25% degradation of RMP under the aforesaid conditions if the ratio of RMP: INH is above 1:0.5.This degradation is reduced to less than 10% when the ratio of RMP: INH is below 1:0.25. Based on these findings, an innovative drug delivery system was designed with the immediate release of RMP and tailored prolonged release of INH. The bilayer tablets prepared with this concept were subjected to relative bioavailability studies in healthy human volunteers in an open label, balanced, randomized, single-dose, cross-over study under fasted state. A validated LC-MS/MS bioanalytical method was employed for estimation of RMP and INH in plasma. Bioavailability studies revealed that C(max) and AUC for RMP increased by 18 and 20%, respectively, confirming the above innovative concept. Even in the case of INH, AUC increased significantly by around 30% and thus time above minimum inhibitory concentration (MIC) would also increase, which may resul...Continue Reading

References

Oct 21, 1999·International Journal of Pharmaceutics·C J ShishooP B Shah
Nov 5, 2003·Diagnostic Microbiology and Infectious Disease·Soo-Young KimChang-Suk Kang
Feb 26, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·D PrabakaranSuresh P Vyas
Feb 3, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Pornsak SriamornsakKingkarn Korkerd
Jul 22, 2008·International Journal of Pharmaceutics·Praveen S Hiremath, Ranendra N Saha

❮ Previous
Next ❯

Citations

Feb 22, 2012·Pharmaceutical Development and Technology·Yongjun WangZhonggui He
Sep 10, 2020·Drug Delivery and Translational Research·Laura Carolina Luciani-GiacobbeMaría Eugenia Olivera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.